Remarkably, both HD and PV or ET MSCs were able to sustain reliable human cell engraftment and maintain the JAK2V617F mutation burden in vivo, suggesting that PV and ET CD34+ HSPCs rely on human stroma for their survival and proliferation. This evidence concerns the gene CD34 and acquired polycythemia vera.